Re: Surrogate Endpoints for Prostate Cancer-Specific Mortality After Radiotherapy and Androgen Suppression Therapy in Men With Localised or Locally Advanced Prostate Cancer: An Analysis of Two Randomised Trials

Locally Advanced ◽

Surrogate Endpoints ◽

Randomised Trials ◽

Specific Mortality ◽

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

The Lancet Oncology ◽

10.1016/s1470-2045(11)70295-9 ◽

2012 ◽

Vol 13 (2) ◽

pp. 189-195 ◽

Cited By ~ 53

Author(s):

Anthony V D'Amico ◽

Ming-Hui Chen ◽

Mario de Castro ◽

Marian Loffredo ◽

David S Lamb ◽

...

Keyword(s):

Prostate Cancer ◽

Locally Advanced ◽

Surrogate Endpoints ◽

Randomised Trials ◽

Specific Mortality ◽

Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2012.06.005 ◽

2012 ◽

Vol 30 (5) ◽

pp. 745

Author(s):

Donald L. Trump

Keyword(s):

Prostate Cancer ◽

Radiation Oncology ◽

Randomized Trials ◽

Locally Advanced ◽

Surrogate Endpoints ◽

Dana Farber Cancer Institute ◽

Specific Mortality ◽

Cancer-specific mortality among Korean men with localized or locally advanced prostate cancer treated with radical prostatectomy versus radiotherapy: A multi-center study using propensity scoring and competing risk regression analyses

European Urology Supplements ◽

10.1016/s1569-9056(17)31813-4 ◽

2017 ◽

Vol 16 (10) ◽

pp. e2659

Author(s):

K.C. Koo ◽

S.H. Lee ◽

S.Y. Cho ◽

S.I. Kim ◽

B.H. Chung ◽

...

Keyword(s):

Prostate Cancer ◽

Locally Advanced ◽

Regression Analyses ◽

Propensity Scoring ◽

Specific Mortality ◽

Multi Center Study ◽

Center Study

217 DOES BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER INVARIABLY IMPACT CANCER-SPECIFIC MORTALITY?

European Urology Supplements ◽

10.1016/s1569-9056(11)60217-0 ◽

2011 ◽

Vol 10 (2) ◽

pp. 90

Author(s):

A. Briganti ◽

N. Suardi ◽

A. Gallina ◽

V. Scattoni ◽

F. Abdollah ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Adjuvant Radiotherapy ◽

Locally Advanced ◽

Specific Mortality ◽

Biochemical Progression ◽

Cancer Specific Mortality

Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses

Cancer Research and Treatment ◽

10.4143/crt.2017.004 ◽

2018 ◽

Vol 50 (1) ◽

pp. 129-137 ◽

Cited By ~ 12

Author(s):

Kyo Chul Koo ◽

Jin Seon Cho ◽

Woo Jin Bang ◽

Seung Hwan Lee ◽

Sung Yong Cho ◽

...

Keyword(s):

Prostate Cancer ◽

Locally Advanced ◽

Regression Analyses ◽

Propensity Scoring ◽

Specific Mortality ◽

Multi Center Study ◽

Center Study

899 DOES BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY AND ADJUVANT RADIOTHERAPY FOR LOCALLY ADVANCED PROSTATE CANCER INVARIABLY IMPACT CANCER-SPECIFIC MORTALITY?

The Journal of Urology ◽

10.1016/j.juro.2011.02.2608 ◽

2011 ◽

Vol 185 (4S) ◽

Author(s):

Alberto Briganti ◽

Nazareno Suardi ◽

Cesare Cozzarini ◽

Andrea Gallina ◽

Umberto Capitanio ◽

...

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Adjuvant Radiotherapy ◽

Locally Advanced ◽

Specific Mortality ◽

Biochemical Progression ◽

Cancer Specific Mortality

Paradoxical metastatic progression following 3months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2013.03.025 ◽

2013 ◽

Vol 107 (2) ◽

pp. 123-128 ◽

Cited By ~ 5

Author(s):

James W. Denham ◽

Allison Steigler ◽

Keen-Hun Tai ◽

David Joseph ◽

John Matthews ◽

...

Keyword(s):

Prostate Cancer ◽

Locally Advanced ◽

Metastatic Progression ◽

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?

European Urology Supplements ◽

10.1016/j.eursup.2010.10.004 ◽

2010 ◽

Vol 9 (11) ◽

pp. 788-793 ◽

Cited By ~ 3

Author(s):

Michel Bolla

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Locally Advanced ◽

Current Status ◽

Androgen Suppression ◽

The Way

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer

Cancer ◽

10.1002/cncr.21989 ◽

2006 ◽

Vol 107 (2) ◽

pp. 389-395 ◽

Cited By ~ 60

Author(s):

Nicholas Bruchovsky ◽

Laurence Klotz ◽

Juanita Crook ◽

Shawn Malone ◽

Charles Ludgate ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Biochemical Recurrence ◽

Phase Ii Trial ◽

Locally Advanced ◽

Intermittent Androgen Suppression ◽

Prospective Phase ◽

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30757-5 ◽

2019 ◽

Vol 20 (2) ◽

pp. 267-281 ◽

Cited By ~ 21

Author(s):

James W Denham ◽

David Joseph ◽

David S Lamb ◽

Nigel A Spry ◽

Gillian Duchesne ◽

...

Keyword(s):

Prostate Cancer ◽

Zoledronic Acid ◽

Locally Advanced ◽

Short Term ◽

Phase 3 ◽

Factorial Trial ◽